Infectious Diseases
Latest News
Gram Stain Doesn’t Improve UTI Diagnosis in the ED
The overall performance of Gram stain in diagnosing a UTI in the ED was comparable to that of automated bacterial counting in urinalysis but...
Latest News
ABIM Revokes Two Physicians’ Certifications Over Accusations of COVID Misinformation
Two critical care docs lose ABIM certification following advocating for ivermectin as a treatment for COVID.
From the Journals
New Era? ‘Double Selective’ Antibiotic Spares the Microbiome
The drug, lolamicin, goes after Gram-negative pathogens.
Latest News
FDA Approves AI Diagnostic Tool for Early Sepsis Detection
Using both biomarkers and clinical data with the assistance of AI, the Sepsis ImmunoScore helps assess the risk for the presence of or progression...
Latest News
The ED Sailed Smoothly in the Early COVID-19 Days
Few ED personnel tested positive for SARS-CoV-2, and the cumulative interaction between infected healthcare personnel and others resulted in a...
Latest News
New Infant RSV Antibody Treatment Shows Strong Results
Babies who received the new preventive treatment for RSV shortly after birth were 90% less likely to be severely sickened.
Commentary
COVID-19 Is a Very Weird Virus
COVID may cause immune system dysfunction that puts patients at risk for autoimmunity.
Latest News
Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse Reactions
The EMA has warned that Paxlovid should only be administered alongside tacrolimus, ciclosporin, everolimus, or sirolimus if their blood levels can...
Latest News
Long COVID Has Caused Thousands of US Deaths: New CDC Data
The risk for long COVID fatalities remains elevated for at least 6 months for people with milder acute infections and for at least 2 years in...
Latest News
Hospital Adverse Events Rise After Private Equity Acquisition
Notably, the incidence of surgical site infections increased from 10.8 per 10,000 hospitalizations before acquisition to 21.6 per 10,000...
Latest News
COVID Strain JN.1 Is Now a ‘Variant of Interest,’ WHO Says
The variant accounted for an estimated 21% of cases for the 2-week period ending December 9, up from 8% during the 2 weeks prior.